Marion Delcroix
Overview
Explore the profile of Marion Delcroix including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
194
Citations
8371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skowasch D, Pausch C, Huscher D, Pittrow D, Wede J, Kreimendahl F, et al.
ESC Heart Fail
. 2025 Mar;
PMID: 40037846
Aims: Pulmonary arterial hypertension (PAH) is often diagnosed in elderly patients with comorbidities. Although initial monotherapy is recommended for these patients, the value of combination therapy remains unclear. Here, we...
2.
De Vos M, Meyns B, Quarck R, Belge C, Godinas L, Rex S, et al.
JTCVS Tech
. 2025 Feb;
29:27.
PMID: 39991310
[This corrects the article DOI: 10.1016/j.xjtc.2024.09.021.].
3.
Muscogiuri E, Van Ballaer V, De Wever W, Di Dedda E, Dubbeldam A, Godinas L, et al.
Echocardiography
. 2025 Feb;
42(2):e70103.
PMID: 39950374
Pulmonary hypertension (PH) is a disease characterized by pathologically increased pressure in the pulmonary arteries, defined by a mean pulmonary arterial pressure (mPAP) >20 mmHg at rest measured with right...
4.
Luijten D, van den Hout W, Boon G, Barco S, Bogaard H, Delcroix M, et al.
ERJ Open Res
. 2025 Jan;
11(1.
PMID: 39811556
Introduction: Achieving an early diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) in pulmonary embolism (PE) survivors results in better quality of life and survival. Importantly, dedicated follow-up strategies to achieve...
5.
De Vos M, Meyns B, Quarck R, Belge C, Godinas L, Rex S, et al.
JTCVS Tech
. 2024 Dec;
28:65-72.
PMID: 39669357
Objective: We aimed to explore the feasibility of an inverted-T upper hemisternotomy approach for pulmonary endarterectomy (PEA) and report the results after 17 cases. Methods: PEA was conducted through a...
6.
Heuts S, Kawczynski M, Leus A, Godinas L, Belge C, van Empel V, et al.
Eur Respir J
. 2024 Nov;
65(2).
PMID: 39572220
Background: We conducted a volume-outcome meta-analysis of pulmonary endarterectomy procedures for chronic thromboembolic pulmonary hypertension to objectively determine the minimum required annual case load that can define a high-volume centre....
7.
Vachiery J, Belge C, Cools B, Damen A, Demeure F, De Pauw M, et al.
Acta Cardiol
. 2024 Oct;
79(9):978-983.
PMID: 39377139
Pulmonary arterial hypertension (PAH) is a rare disease affecting the small pulmonary vessels, ultimately leading to right ventricular failure and death. Current treatment options target three different pathways (endothelin, nitric...
8.
Kim N, Channick R, Delcroix M, Madani M, Pepke-Zaba J, Borissoff J, et al.
Eur Respir J
. 2024 Sep;
64(4).
PMID: 39326918
Background: SELECT was the first global randomised controlled trial of selexipag with standard of care in patients with inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension. Methods: SELECT was a multicentre,...
9.
Klok F, Vago E, Horvath-Puho E, Barco S, Andersen A, Bonnesen K, et al.
J Thromb Haemost
. 2024 Sep;
22(12):3562-3571.
PMID: 39306096
Background: A considerable number of patients with chronic thromboembolic pulmonary hypertension (CTEPH) lack a history of venous thromboembolism (VTE). Objectives: We aimed to examine the annual incidence and prevalence of...
10.
Delcroix M, Pepke-Zaba J, DArmini A, Fadel E, Guth S, Hoole S, et al.
Circulation
. 2024 Sep;
150(17):1354-1365.
PMID: 39286890
Background: The European Chronic Thromboembolic Pulmonary Hypertension (CTEPH) registry, conducted between 2007 and 2012, reported the major impact of pulmonary endarterectomy (PEA) on the long-term survival of patients with CTEPH....